BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 32513686)

  • 1. Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.
    Lamble AJ; Kosaka Y; Laderas T; Maffit A; Kaempf A; Brady LK; Wang W; Long N; Saultz JN; Mori M; Soong D; LeFave CV; Huang F; Adams H; Loriaux MM; Tognon CE; Lo P; Tyner JW; Fan G; McWeeney SK; Druker BJ; Lind EF
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14331-14341. PubMed ID: 32513686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
    Williams P; Basu S; Garcia-Manero G; Hourigan CS; Oetjen KA; Cortes JE; Ravandi F; Jabbour EJ; Al-Hamal Z; Konopleva M; Ning J; Xiao L; Hidalgo Lopez J; Kornblau SM; Andreeff M; Flores W; Bueso-Ramos C; Blando J; Galera P; Calvo KR; Al-Atrash G; Allison JP; Kantarjian HM; Sharma P; Daver NG
    Cancer; 2019 May; 125(9):1470-1481. PubMed ID: 30500073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia.
    Wan Y; Zhang C; Xu Y; Wang M; Rao Q; Xing H; Tian Z; Tang K; Mi Y; Wang Y; Wang J
    BMC Cancer; 2020 May; 20(1):472. PubMed ID: 32456622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia.
    Zahran AM; Mohammed Saleh MF; Sayed MM; Rayan A; Ali AM; Hetta HF
    Cancer Biomark; 2018; 22(3):587-595. PubMed ID: 29843224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scrutinizing the Expression and Blockade of Inhibitory Molecules Expressed on T Cells from Acute Myeloid Leukemia Patients.
    Abdolmaleki M; Mojtabavi N; Zavvar M; Vaezi M; Noorbakhsh F; Nicknam MH
    Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):265-273. PubMed ID: 29908544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia.
    Sun YX; Kong HL; Liu CF; Yu S; Tian T; Ma DX; Ji CY
    Hum Immunol; 2014 Feb; 75(2):113-8. PubMed ID: 24269703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate acid promotes PD-1
    Zhang Y; Huang Y; Hong Y; Lin Z; Zha J; Zhu Y; Li Z; Wang C; Fang Z; Zhou Z; Peng Y; Yu X; Liu L; Xu B
    Int Immunopharmacol; 2024 Mar; 130():111765. PubMed ID: 38447414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia.
    Aru B; Pehlivanoğlu C; Dal Z; Dereli-Çalışkan NN; Gürlü E; Yanıkkaya-Demirel G
    Front Immunol; 2023; 14():1108200. PubMed ID: 36742324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation.
    Kong Y; Zhang J; Claxton DF; Ehmann WC; Rybka WB; Zhu L; Zeng H; Schell TD; Zheng H
    Blood Cancer J; 2015 Jul; 5(7):e330. PubMed ID: 26230954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT.
    Noviello M; Manfredi F; Ruggiero E; Perini T; Oliveira G; Cortesi F; De Simone P; Toffalori C; Gambacorta V; Greco R; Peccatori J; Casucci M; Casorati G; Dellabona P; Onozawa M; Teshima T; Griffioen M; Halkes CJM; Falkenburg JHF; Stölzel F; Altmann H; Bornhäuser M; Waterhouse M; Zeiser R; Finke J; Cieri N; Bondanza A; Vago L; Ciceri F; Bonini C
    Nat Commun; 2019 Mar; 10(1):1065. PubMed ID: 30911002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and clinical correlation of TIM-3 and PD-1/PD-L1 expressions in leukemic cells and tumor microenvironment in newly diagnosed acute myeloid leukemia.
    Chajuwan T; Kansuwan P; Kobbuaklee S; Chanswangphuwana C
    Leuk Lymphoma; 2022 Feb; 63(2):450-456. PubMed ID: 34585994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed cell death protein 1 activation preferentially inhibits CD28.CAR-T cells.
    Zolov SN; Rietberg SP; Bonifant CL
    Cytotherapy; 2018 Oct; 20(10):1259-1266. PubMed ID: 30309710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?
    Ustun C; Miller JS; Munn DH; Weisdorf DJ; Blazar BR
    Blood; 2011 Nov; 118(19):5084-95. PubMed ID: 21881045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune receptor repertoires in pediatric and adult acute myeloid leukemia.
    Zhang J; Hu X; Wang J; Sahu AD; Cohen D; Song L; Ouyang Z; Fan J; Wang B; Fu J; Gu S; Sade-Feldman M; Hacohen N; Li W; Ying X; Li B; Liu XS
    Genome Med; 2019 Nov; 11(1):73. PubMed ID: 31771646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Immune Checkpoint Receptors on T-Cells and Their Ligands on Leukemia Blasts in Childhood Acute Leukemia.
    Kang SH; Hwang HJ; Yoo JW; Kim H; Choi ES; Hwang SH; Cho YU; Jang S; Park CJ; Im HJ; Seo JJ; Kim N; Koh KN
    Anticancer Res; 2019 Oct; 39(10):5531-5539. PubMed ID: 31570447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased PD-1 expression of bone marrow T-cells in acute myeloid leukaemia patients after stem cell transplantation, and its association with overall survival.
    You E; Park CJ; Cho YU; Jang S; Lee MY; Kim H; Koh KN; Im HJ; Choi EJ; Lee JH; Lee KH
    Ann Clin Biochem; 2024 Mar; 61(2):79-89. PubMed ID: 37314798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia.
    Ladikou EE; Sivaloganathan H; Pepper A; Chevassut T
    Curr Oncol Rep; 2020 Feb; 22(3):27. PubMed ID: 32048054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
    Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
    Front Immunol; 2018; 9():2227. PubMed ID: 30319662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.